Devereux H - Search Results

1

The prevalence of non-B subtype HIV-1 in a London HIV/AIDS outpatient clinic.

Devereux H, Loveday C, Burke A, Dann L, Johnson M, Phillips A. Devereux H, et al. AIDS. 1999 Jan 14;13(1):142. AIDS. 1999. PMID: 10207561 No abstract available.

2

High prevalence of multiple drug resistance mutations in a UK HIV/AIDS patient population.

Loveday C, Devereux H, Huckett L, Johnson M. Loveday C, et al. Among authors: devereux h. AIDS. 1999 Apr 1;13(5):627-8. doi: 10.1097/00002030-199904010-00017. AIDS. 1999. PMID: 10203393 No abstract available.

3

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy.

Devereux HL, Youle M, Johnson MA, Loveday C. Devereux HL, et al. AIDS. 1999 Dec 24;13(18):F123-7. AIDS. 1999. PMID: 10630517

4

Immune markers and viral load after HIV-1 seroconversion as predictors of disease progression in a cohort of haemophilic men.

Sabin CA, Devereux H, Phillips AN, Janossy G, Loveday C, Lee CA. Sabin CA, et al. Among authors: devereux h. AIDS. 1998 Jul 30;12(11):1347-52. doi: 10.1097/00002030-199811000-00017. AIDS. 1998. PMID: 9708415

5

In vivo HIV-1 replicative capacity in early and advanced infection.

Phillips AN, McLean AR, Loveday C, Tyrer M, Bofill M, Devereux H, Madge S, Dykoff A, Drinkwater A, Burke A, Huckett L, Janossy G, Johnson MA. Phillips AN, et al. Among authors: devereux h. AIDS. 1999 Jan 14;13(1):67-73. doi: 10.1097/00002030-199901140-00009. AIDS. 1999. PMID: 10207546

6

Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapy.

Sabin CA, Yee TT, Devereux H, Griffioen A, Loveday C, Phillips AN, Lee CA. Sabin CA, et al. Among authors: devereux h. AIDS. 2000 May 26;14(8):1001-7. doi: 10.1097/00002030-200005260-00012. AIDS. 2000. PMID: 10853982

7

Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV Medicine.

Mocroft A, Devereux H, Kinloch-de-Loes S, Wilson D, Madge S, Youle M, Tyrer M, Loveday C, Phillips AN, Johnson MA. Mocroft A, et al. Among authors: devereux h. AIDS. 2000 Jul 28;14(11):1545-52. doi: 10.1097/00002030-200007280-00010. AIDS. 2000. PMID: 10983641 Clinical Trial.

8

Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients.

Devereux HL, Loveday C, Youle M, Sabin CA, Burke A, Johnson M. Devereux HL, et al. AIDS Res Hum Retroviruses. 2000 Jul 20;16(11):1025-30. doi: 10.1089/08892220050075273. AIDS Res Hum Retroviruses. 2000. PMID: 10933616

9

In vivo HIV-1 compartmentalisation: drug resistance-associated mutation distribution.

Devereux HL, Burke A, Lee CA, Johnson MA. Devereux HL, et al. J Med Virol. 2002 Jan;66(1):8-12. doi: 10.1002/jmv.2104. J Med Virol. 2002. PMID: 11748652

10

Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.

Mocroft A, Sabin CA, Youle M, Madge S, Tyrer M, Devereux H, Deayton J, Dykhoff A, Lipman MC, Phillips AN, Johnson MA. Mocroft A, et al. Among authors: devereux h. J Acquir Immune Defic Syndr. 1999 Aug 15;21(5):401-7. J Acquir Immune Defic Syndr. 1999. PMID: 10458621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters